The vision: AI-first enterprises that reshape life sciences
2 Min. LesezeitSix months from now, your organization could look different. Research teams compress discovery timelines by months as AI agents synthesize decades of literature and surface novel targets. Regulatory teams prepare submissions in weeks instead of quarters, with assistants that understand CFR, ICH guidelines, and global requirements. Clinical operations resolve protocol questions and safety signals in near real time.
The deeper change goes beyond efficiency. AI-first life sciences organizations bring therapies to patients faster, catch safety signals earlier, and draw out insight buried in decades of clinical and real-world data. They free every scientist to focus on discovery and every regulatory team to build stronger submissions.
The question isn't whether AI will reshape life sciences. It's whether your organization will lead that change or follow competitors who moved first.
Ready to begin your AI transformation?
Join organizations already putting Claude to work.
- Contact Anthropic's Sales team (opens in new tab) to discuss your use cases and implementation strategy
- Learn about Claude for Life Sciences (opens in new tab), trusted by organizations like Eli Lilly, AbbVie, and Sanofi to accelerate scientific discovery
- Access Claude through the Claude for Microsoft 365 (opens in new tab), Claude Cowork (opens in new tab), and Claude Code (opens in new tab)
- Review our enterprise documentation and safety guidelines at docs.anthropic.com (opens in new tab) and the Trust Center (opens in new tab)
- Explore Claude Code (opens in new tab) to accelerate scientific and regulatory engineering workflows